
Narayana Hrudayalaya Q2 Results: Margin Recovery in Focus After UK-Led Revenue Jump
Updated: 23 Sept 2026 • 5:23 pm
Posted by:

Quick Answer
Narayana Hrudayalaya's Q2 FY27 results date is not yet confirmed. Q1 FY27 (June 2026 quarter) consolidated revenue jumped 78% YoY to Rs 2,683.63 crore on the full-quarter integration of its UK acquisition, though EBITDA margin compressed to 18.82% from 23.93%. The Q2 FY27 print will be compared against a Q2 FY26 base of Rs 1,643.79 crore revenue and Rs 258.50 crore PAT, with margin recovery the key swing factor.
The Narayana Hrudayalaya Q2 results FY27 print is the next earnings event for this multi-continent hospital chain, arriving as the market judges whether the margin compression seen in Q1 FY27 was a one-quarter integration cost or a lasting shift.
Click Here – Get Free Investment Predictions
When Is the Narayana Hrudayalaya Q2 Results FY27 Date?
Not confirmed; Q1 FY27 was reported on August 3, 2026, so a mid-to-late November date follows the pattern for the September 2026 quarter.
Narayana Hrudayalaya Q2 Results Expectations
No verified consensus exists. The Narayana Hrudayalaya Q2 results watchlist centres on whether EBITDA margin recovers from Q1 FY27's compressed 18.82% (down from 23.93% YoY) as UK integration costs normalise, and whether India hospital operations sustain the 17% YoY growth seen in Q1.
Narayana Hrudayalaya Previous Quarter Performance (Q1 FY27)
Revenue Rs 2,683.63 crore (+78.04% YoY), EBITDA Rs 505.18 crore (+40.04% YoY, margin 18.82%), consolidated PAT Rs 207.27 crore (+5.72% YoY). The UK business contributed Rs 825.7 crore; India hospitals grew 17.0% YoY to Rs 1,324.7 crore.
Narayana Hrudayalaya Q2 FY26 Base Quarter
Revenue Rs 1,643.79 crore, PBIT Rs 339.02 crore, consolidated PAT Rs 258.50 crore, EPS Rs 12.72.
Narayana Hrudayalaya Recent Quarterly Trend
| Quarter | Revenue (Rs Cr) | PAT (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep-25) | 1,643.79 | 258.50 |
| Jun-25 | 1,507.27 | 197.15 |
| Mar-25 | 1,475.44 | 197.29 |
| Q1 FY27 (Jun-26) | 2,683.63 | 207.27 |
Key Factors That Could Shape Narayana Hrudayalaya Q2 Results FY27
- UK integration cost trajectory
- Doctor professional fees
- India hospital occupancy and ARPOB
- Cayman business performance
- Net debt-to-equity, currently 0.42x
Narayana Hrudayalaya Q2 Results FY27: Valuation Going Into the Print
No forward valuation is implied here; readers should check trailing multiples via a verified source before the print.
Download the Univest iOS App or Univest Android App to track Narayana Hrudayalaya live price and quarterly earnings updates.
What Investors Should Watch When Narayana Hrudayalaya Q2 Results Are Announced
- EBITDA margin recovery toward the 23%+ range seen a year ago
- UK segment profitability
- Whether India same-hospital growth sustains 17%+
Conclusion on Narayana Hrudayalaya Q2 Results FY27
The Narayana Hrudayalaya Q2 results FY27 print will be watched for margin normalisation after Q1's UK-integration-driven compression, against a Q2 FY26 base of Rs 258.50 crore PAT.
FAQs on Narayana Hrudayalaya Q2 Results FY27
What is the Narayana Hrudayalaya Q2 results date for FY27?
Ans. Not confirmed; Q1 FY27 was reported August 3, 2026, so a mid-to-late November date follows the historical pattern.
What were Narayana Hrudayalaya's Q1 FY27 results?
Ans. Revenue of Rs 2,683.63 crore (+78% YoY) and PAT of Rs 207.27 crore (+5.7% YoY), with EBITDA margin compressing to 18.82%.
What was the Q2 FY26 base quarter for Narayana Hrudayalaya?
Ans. Revenue Rs 1,643.79 crore and PAT Rs 258.50 crore, the comparison base for Q2 FY27.
Is Narayana Hrudayalaya a buy ahead of Q2 results?
Ans. This article offers no buy, sell or hold recommendation; consult a SEBI-registered advisor.
Check Narayana Hrudayalaya Live Fundamentals on the Univest Screener
{"@context":"https://schema.org","@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What is the Narayana Hrudayalaya Q2 results date for FY27?","acceptedAnswer":{"@type":"Answer","text":"Not confirmed; Q1 FY27 was reported August 3, 2026, so a mid-to-late November date follows the historical pattern."}},{"@type":"Question","name":"What were Narayana Hrudayalaya's Q1 FY27 results?","acceptedAnswer":{"@type":"Answer","text":"Revenue of Rs 2,683.63 crore (+78% YoY) and PAT of Rs 207.27 crore (+5.7% YoY), with EBITDA margin compressing to 18.82%."}},{"@type":"Question","name":"What was the Q2 FY26 base quarter for Narayana Hrudayalaya?","acceptedAnswer":{"@type":"Answer","text":"Revenue Rs 1,643.79 crore and PAT Rs 258.50 crore, the comparison base for Q2 FY27."}},{"@type":"Question","name":"Is Narayana Hrudayalaya a buy ahead of Q2 results?","acceptedAnswer":{"@type":"Answer","text":"This article offers no buy, sell or hold recommendation; consult a SEBI-registered advisor."}}]}
Recent Articles

Buy, Sell Or Hold: Everest Industries, Visaka Industries, Ramco Industries, Sagar Cements, Shree Digvijay Cement — Analyst Forecast
23 September 2026

Buy, Sell Or Hold: UltraTech Cement, Ambuja Cements, ACC, Shree Cement, Dalmia Bharat — Analyst Forecast
23 September 2026

Buy, Sell Or Hold: Bharat Forge, Ramkrishna Forgings, MM Forgings, Sundaram Clayton, Craftsman Automation — Analyst Forecast
23 September 2026

Buy, Sell Or Hold: Larsen and Toubro, Cummins India, Thermax, Kirloskar Oil Engines, ISGEC Heavy Engineering — Analyst Forecast
23 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Buy, Sell Or Hold: Everest Industries, Visaka Industries, Ramco Industries, Sagar Cements, Shree Digvijay Cement — Analyst Forecast
Buy, Sell Or Hold: UltraTech Cement, Ambuja Cements, ACC, Shree Cement, Dalmia Bharat — Analyst Forecast
Buy, Sell Or Hold: Bharat Forge, Ramkrishna Forgings, MM Forgings, Sundaram Clayton, Craftsman Automation — Analyst Forecast
Buy, Sell Or Hold: Larsen and Toubro, Cummins India, Thermax, Kirloskar Oil Engines, ISGEC Heavy Engineering — Analyst Forecast
Buy, Sell Or Hold: Siemens, ABB India, CG Power and Industrial Solutions, Hitachi Energy India, BHEL — Analyst Forecast

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





